AIDS-related Burkitt lymphoma-A heterogeneous disease?

Leukemia Research

Volumn 32, Issue 12, 2008, Pages 1939-1941

  Danilov, Alexey V ^a   Pilichowska, Monika ^a   Danilova, Olga V ^b   Sprague, Kellie A ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; METHOTREXATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANAMNESIS; BURKITT LYMPHOMA; CASE REPORT; CHROMOSOME ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LABORATORY TEST; LETTER; MALE; NECK TUMOR; PRIORITY JOURNAL; TUMOR BIOPSY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BURKITT LYMPHOMA; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HUMANS; IN SITU HYBRIDIZATION; LYMPHOMA, AIDS-RELATED; MALE; MITOSIS; PHAGOCYTOSIS; RNA, MESSENGER; RNA, VIRAL; SUBMANDIBULAR GLAND NEOPLASMS; TREATMENT OUTCOME; VINCRISTINE;

EID: 51649094525     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.03.037     Document Type: Letter

References (11)

1. Hishima T., Oyaizu N., Fujii T., Tachikawa N., Ajisawa A., Negishi M., et al. Decrease in Epstein-Barr virus-positive AIDS-related lymphoma in the era of highly active antiretroviral therapy. Microbes Infect 8 (2006) 1301-1307
2. Davi F., Delecluse H.J., Guiet P., Gabarre J., Fayon A., Gentilhomme O., et al. Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas Burkitt's Lymphoma Study Group. J Clin Oncol 16 (1998) 3788-3795
3. Biggar R.J., Chaturvedi A.K., Goedert J.J., and Engels E.A. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 99 (2007) 962-972
4. Cortes J., Thomas D., Rios A., Koller C., O'Brien S., Jeha S., et al. Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cancer 94 (2002) 1492-1499
5. Spina M., Tirelli U., Zagonel V., Gloghini A., Volpe R., Babare R., et al. Burkitt's lymphoma in adults with and without human immunodeficiency virus infection: a single-institution clinicopathologic study of 75 patients. Cancer 82 (1998) 766-774
6. Otieno M.W., Remick S.C., and Whalen C. Adult Burkitt's lymphoma in patients with and without human immunodeficiency virus infection in Kenya. Int J Cancer 92 (2001) 687-691
7. Liang C.W., Li H.Y., Chang K.P., Chen C.K., and Chen Y.L. HIV infection initially presenting as sinonasal Burkitt's lymphoma. Am J Otolaryngol 27 (2006) 433-435
8. Gaidano G., Pastore C., Gloghini A., Canzonieri V., Capello D., Franceschi S., et al. Genetic heterogeneity of AIDS-related small non-cleaved cell lymphoma. Br J Haematol 98 (1997) 726-732
9. Bellan C., Lazzi S., Hummel M., Palummo N., de Santi M., Amato T., et al. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 106 (2005) 1031-1036
10. Galicier L., Fieschi C., Borie R., Meignin V., Daniel M.T., Gerard L., et al. Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study. Blood 110 (2007) 2846-2854
11. Wang E.S., Straus D.J., Teruya-Feldstein J., Qin J., Portlock C., Moskowitz C., et al. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer 98 (2003) 1196-1205